 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Allergan Specialty Therapeutics, Inc.
 |
Allergan Specialty Therapeutics, Inc. |
 |
 |
 |
PROFILE |
 |
Allergan Specialty Therapeutics, Inc. (ASTI) is a development-stage company that concentrates on drugs based on retinoid and neuroprotective technologies developed by its former parent Allergan, Inc. ASTI's potential products include Tazarotene, for treatment of cancer, acne, and psoriasis; Memantine, for halting optic nerve damage from glaucoma and other eye diseases; AGN 194310, for treatment of skin diseases; and Androgen Tears, to combat dry-eyes disease. The company will license successful pharmaceuticals back to Allergan. ASTI is collaborating with such partners as Cambridge NeuroSciences and Cytochroma to fund research into potential treatments for other optical and skin ailments.
COMPETITION |
 |
Alcon Laboratories, Inc. (dossier)
Ligand Pharmaceuticals Incorporated (LGND)
Pharmos Corporation (PARS)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 3.20
1-Yr. Sales Growth: (54.9)%
Employees: 1
Revenue per employee: $3,200,000.00
KEY PEOPLE |
 |
William C. Shepherd
CEO
James M. Hindman
CFO
CONTACT INFO |
 |
2525 Dupont Dr.
Irvine, CA 92612
US
Phone: 714-246-4500
Fax: 714-246-4162
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |